Key facts
- This page summarizes Adrian Haigh's Form 4 filing for FENNEC PHARMACEUTICALS INC. (FENC).
- 6 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 22 Apr 2024, 19:34.
Adrian Haigh - 19 Apr 2024 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)
- Reporting relationship
- CHIEF OPERATING OFFICER
- Issuer ticker
- FENC
- Reported as of
- 19 Apr 2024
- Net transaction value
- -$414,472
- SEC form
- 4
- Accepted by SEC
- 22 Apr 2024, 19:34:12 UTC
- Prior SEC filing
- 26 Apr 2024
- Next SEC filing
- 21 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Adrian Haigh
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Adrian Haigh filed Form 4 for FENNEC PHARMACEUTICALS INC. (FENC) on 22 Apr 2024.
Change
- Previous filing in this sequence was filed on 26 Apr 2024.
- Current net transaction value: -$414,472.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FENC
transaction
Common Shares
Options Exercise
- Transaction value
- $51,333
- Shares
- +22,222
- Change %
- Price
- $2.31
- Shares after
- 22,222
- Date
- 19 Apr 2024
- Ownership
- Direct
- Footnotes
- F1
FENC
transaction
Common Shares
Sale
- Transaction value
- $207,442
- Shares
- -22,222
- Change %
- -100%
- Price
- $9.34
- Shares after
- 0
- Date
- 19 Apr 2024
- Ownership
- Direct
- Footnotes
- F2
FENC
transaction
Common Shares
Options Exercise
- Transaction value
- $51,335
- Shares
- +22,223
- Change %
- Price
- $2.31
- Shares after
- 22,223
- Date
- 22 Apr 2024
- Ownership
- Direct
- Footnotes
- F3
FENC
transaction
Common Shares
Sale
- Transaction value
- $207,029
- Shares
- -22,223
- Change %
- -100%
- Price
- $9.32
- Shares after
- 0
- Date
- 22 Apr 2024
- Ownership
- Direct
- Footnotes
- F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
FENC
transaction
Derivative
Option
Options Exercise
- Transaction value
- $51,333
- Shares
- -22,222
- Change %
- -5.5%
- Price
- $2.31
- Shares after
- 382,469
- Date
- 19 Apr 2024
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 22,222
- Exercise price
- $2.31
- Footnotes
- F5
FENC
transaction
Derivative
Option
Options Exercise
- Transaction value
- $51,335
- Shares
- -22,223
- Change %
- -5.8%
- Price
- $2.31
- Shares after
- 360,246
- Date
- 22 Apr 2024
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 22,223
- Exercise price
- $2.31
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 6 footnotes
Footnote F1
Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
Footnote F2
Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023.
Footnote F3
Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
Footnote F4
Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023.
Footnote F5
Represents option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
Footnote F6
Represents option exercise pursuant to a 10b5-1 plan dated August 17, 2023.